Journal
JOURNAL OF HEPATOLOGY
Volume 39, Issue 2, Pages 262-268Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(03)00215-0
Keywords
telomerase; murine telomerase reverse transcriptase; telomere; HBV X protein; transgenic mice; hepatocellular carcinoma; hepatitis B
Categories
Ask authors/readers for more resources
Background/Aims: Transgenic mice that express HBV X protein (HBx) have increased sensitivity to hepatocarcinogens. In the present study, we hypothesized that HBx interferes with the DNA protective increases in telomerase activity that occur in proliferating hepatocytes. Methods: Male CD-1 mice (4-6/grp) were killed and hepatic telomerase activity measured at 0, 6,12,24,36,48 h post partial hepatectomy (PHx). Four HBx transgenic mice were killed at 12 h post-PHx when maximum telomerase activity was observed in CD-1 non-transgenic mice. mRNA of the telomerase catalytic subunit; murine telomerase reverse transcriptase (mTERT), was measured by reverse transcription-polymerase chain reaction. Telomerase activity and human TERT (hTERT) were also measured in Chang and PLC/PRF/5 cells following transient transfection with HBx cDNA. Results: Telomerase activity peaked at 12 h post-PHx in normal mice, however, in HBx transgenic mice, telomerase activity was significantly lower, both at baseline (P < 0.05) and 12 h post-PHx (P < 0.01). Following PHx, mTERT mRNA expression remained constant in normal mice but decreased significantly (P < 0.01) in HBx transgenic mice. Transfection of HBx in Chang and PLC/PRF/5 cells had no effect on telomerase activity or hTERT mRNA expression. Conclusions: The results of this study suggest that HBx expression may play a role in hepatocellular carcinogenesis by interfering with telomerase activity during hepatocyte proliferation. (C) 2003 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available